Predictors of galcanezumab response in a real-world study of Korean patients with migraine

被引：0
|
作者：
Kim, Seung Ae [1 ]
Lee, Mi Ji [1 ]
Jang, Hyemin [2 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
[2] Samsung Med Ctr, Seoul, South Korea
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [21] Efficacy of Galcanezumab for the treatment of migraine in Korea: the first real-world data from an Asian country
    Kwon, S.
    Gil, Y. E.
    Lee, M. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 52 - 52
  • [22] Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
    Silvestro, Marcello
    Tessitore, Alessandro
    Orologio, Ilaria
    De Micco, Rosa
    Tartaglione, Lorenzo
    Trojsi, Francesca
    Tedeschi, Gioacchino
    Russo, Antonio
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [23] Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
    Marcello Silvestro
    Alessandro Tessitore
    Ilaria Orologio
    Rosa De Micco
    Lorenzo Tartaglione
    Francesca Trojsi
    Gioacchino Tedeschi
    Antonio Russo
    The Journal of Headache and Pain, 2022, 23
  • [24] A real-world prospective observational study of eptinezumab in Asian patients with migraine
    Zhao, Yi Jing
    Ong, Jonathan Jia Yuan
    Sonu, Sumit Kumar
    Dang, Jiaojiao
    Ng, Chai Ching
    Herr, Keira Joann
    Bose, Rohini
    Jion, Yasmin Idu
    HEADACHE, 2024, 64 (07): : 810 - 824
  • [25] Real-world insights on the management of migraine patients: an Italian nationwide study
    Agostoni, Elio
    Barbanti, Piero
    Frediani, Fabio
    Trifiro, Gianluca
    Burgio, Luigi
    di Nola, Lisa
    Pegoraro, Valeria
    Pulimeno, Stefania
    Cepparulo, Mario
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (09) : 1545 - 1554
  • [26] Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
    Gaul, Charly
    Gendolla, Astrid
    Holle, Dagny
    Goebel, Hartmut
    Koch, Mirja
    Baufeld, Caroline
    Weiss, Cordula
    PAIN AND THERAPY, 2024, 13 (06) : 1659 - 1678
  • [27] A real-world, observational study of erenumab for migraine prevention in Canadian patients
    Becker, Werner J.
    Spacey, Sian
    Leroux, Elizabeth
    Giammarco, Rose
    Gladstone, Jonathan
    Christie, Suzanne
    Akaberi, Arash
    Power, G. Sarah
    Minhas, Jagdeep K.
    Mancini, Johanna
    Rochdi, Driss
    Filiz, Ayca
    Bastien, Natacha
    HEADACHE, 2022, 62 (04): : 522 - 529
  • [28] Effectiveness and Response Predictors of Omalizumab in Treating Patients with Seasonal Allergic Rhinitis: A Real-World Study
    Ma, Tingting
    Wang, Hongtian
    Wang, Xueyan
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 59 - 66
  • [29] One-year outcome of Galcanezumab1 in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UK
    Khan, Rafiullah
    Delrosario, Helen
    Dorsey, Sophie
    Ijaz, Aamir
    Ahmed, Fayyaz
    CEPHALALGIA, 2023, 43 (1supp)
  • [30] Real-world effectiveness of erenumab in Japanese patients with migraine
    Suzuki, Keisuke
    Suzuki, Shiho
    Shiina, Tomohiko
    Haruyama, Yasuo
    Kobayashi, Saro
    Shioda, Mukuto
    Hirata, Koichi
    HELIYON, 2024, 10 (04)
12345